Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    14988823 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Mesalazine Therapy in Patients With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Interventions: Drug: Mesalazine;   Drug: Placebo
2 Completed Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study
Condition: Irritable Bowel Syndrome
Intervention: Dietary Supplement: Lactobacillus casei DG

Indicates status has not been verified in more than two years